Merck & Cie competitive analysis

Explore Merck & Cie's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jul 16, 2026
Patent NumberPublication DateTitleTotal Oppositions
Jun 12, 2019Crystalline Forms Of (6R) -L-Erythro-Tetrahydrobiopterin Dihydrochloride1

Latest PTAB cases involving Merck & Cie

Discover the latest PTAB cases involving Merck & Cie, highlighting their recent legal challenges and patent disputes.

Last updated on: Jul 16, 2026
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Merck & Cie

IPR2013-00117Jan 24, 2013GNOSISMERCK & CIEFinal Written Decision

Peer Comparison New

IP litigation analysis comparing Merck & Cie with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Jul 16, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
MERCK & CIE - 1 - 1
GNOSIS - - 4 -
LEDERER & KELLER43 - - -